share_log

Exicure | 8-K: Current report

SEC announcement ·  Apr 23 04:23
Summary by Futu AI
On April 17, 2024, Exicure, Inc., a biotechnology company, received a delinquency notification from the Nasdaq Stock Market for not filing its annual report on Form 10-K for the year ended December 31, 2023. This failure to file has resulted in non-compliance with Nasdaq Listing Rule 5250(c)(1), which mandates timely submission of periodic financial reports to the SEC. The company had previously been granted an extension until May 20, 2024, to file its delinquent third quarter Form 10-Q and now must also file the overdue Form 10-K by the same date to regain compliance. Exicure's management is actively working to complete the Form 10-K and plans to submit it as soon as possible. The company, which has suspended its clinical and development activities, is currently exploring strategic alternatives to enhance stockholder value.
On April 17, 2024, Exicure, Inc., a biotechnology company, received a delinquency notification from the Nasdaq Stock Market for not filing its annual report on Form 10-K for the year ended December 31, 2023. This failure to file has resulted in non-compliance with Nasdaq Listing Rule 5250(c)(1), which mandates timely submission of periodic financial reports to the SEC. The company had previously been granted an extension until May 20, 2024, to file its delinquent third quarter Form 10-Q and now must also file the overdue Form 10-K by the same date to regain compliance. Exicure's management is actively working to complete the Form 10-K and plans to submit it as soon as possible. The company, which has suspended its clinical and development activities, is currently exploring strategic alternatives to enhance stockholder value.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.